Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 September 2019 | Story Ruan Bruwer | Photo Tania Allen
Netball
The Kovsies will face the Maties in the semi-finals of Varsity Netball in search of their fourth appearance in a final.

On Monday (30 September), the University of the Free State (UFS) netball team will have an ideal opportunity for revenge for what happened in this year’s Varsity Cup. In the semi-finals of the Varsity Cup back in April, the Shimla rugby team received a decent hiding from the Maties.

Now the UFS and Maties will face each other in another semi-final, this time in the netball version of the Varsity Cup, called Varsity Netball. The teams square off in the Callie Human Centre at 17:00.

Since losing to Tuks in the opening round, Kovsies have built up good momentum and confidence with six consecutive victories, including one over the Stellenbosch students on Monday (23 September). The score was 65-61.

The other wins were against UJ (69-35), TUT (64-20), NWU (59-55), Madibaz (70-41), and UWC (99-18), earning them the second spot on the log behind Tuks. The 99 goals against UWC were their best ever in the competition.The Free State women also won their encounter against Maties at this year’s USSA tournament by 38-31.

A victory would earn the team a shot at another Varsity Netball title. They have never lost a final, having appeared in three previous finals (2013, 2014, and 2018). Kovsies have won three of their previous five Varsity Netball semi-finals. They had met Maties only once before in a semi-final. This was last year in Bloemfontein when Kovsies prevailed by 56-45.
Khomotso Mamburu, goal defence of Maties, and Adéle Niemand, their assistant coach, both represented the Kovsies for many years.

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept